Arbutus Biopharma Corporation ABUS Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's common stock shares issued?
- Arbutus Biopharma Corporation (ABUS) reported common stock shares issued of 196.9M in Q1 2026.
- How has Arbutus Biopharma Corporation's common stock shares issued changed year-over-year?
- Arbutus Biopharma Corporation's common stock shares issued increased by 2.9% year-over-year, from 191.5M to 196.9M.
- What is the long-term trend for Arbutus Biopharma Corporation's common stock shares issued?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's common stock shares issued has grown at a 16.5% compound annual growth rate (CAGR), from 89.7M to 192.5M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.